Annals of Surgical Oncology

, Volume 19, Issue 7, pp 2380–2387 | Cite as

Treatment Management of Small Renal Masses in the 21st Century: A Paradigm Shift

  • Maxine Sun
  • Firas Abdollah
  • Marco Bianchi
  • Quoc-Dien Trinh
  • Claudio Jeldres
  • Rodolphe Thuret
  • Zhe Tian
  • Shahrokh F. Shariat
  • Francesco Montorsi
  • Paul Perrotte
  • Pierre I. Karakiewicz
Urologic Oncology

Abstract

Background

Partial (PN) or radical nephrectomy (RN) represents the standard of care for patients with small renal masses. Active surveillance (AS) also may be considered. We examined the rates of PN, RN, and AS within a contemporary population-based cohort.

Methods

Using the surveillance, epidemiology and end results database, we identified 26,468 patients diagnosed with T1aN0M0 renal cell carcinoma, between years 1988 and 2008. Determinants of PN and AS were assessed using logistic regression analyses within surgically managed patients and within the entire cohort, respectively.

Results

Overall, 8,966 (34%), 14,705 (56%), and 2,797 (11%) patients underwent PN, RN, and AS, respectively. The rate of PN increased (4.7% in 1988 to 40.4% in 2008, P < 0.001), whereas the rate of RN decreased over time (92.9% in 1988 to 41.4% in 2008, P < 0.001). The rate of AS increased over time (2.4% in 1988 to 18.2% in 2008, P < 0.001). In multivariable analyses, the determinants for PN consisted of more contemporary year of diagnosis, younger patient age, male gender, Caucasian race, married status, and decreasing tumor size (all P ≤ 0.003). The determinants of AS consisted of more contemporary year of diagnosis, more advanced age, male gender, decreasing tumor size, and unmarried marital status (all P ≤ 0.001). Regional differences for management of localized RCC were detected.

Conclusions

It is encouraging that PN rates have increased in an eightfold fashion. Moreover, a fivefold increase was recorded for AS. These figures show a paradigm shift in the management of small renal masses.

References

  1. 1.
    Lee C, Katz J, Shi W, Thaler H, Reuter V, Russo P. Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol. 2000;163:730–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Nguyen M, Gill I, Ellison L. The evolving presentation of renal carcinoma in the United States: trends from the surveillance, epidemiology and end results program. J Urol. 2006;176:2397–2400.PubMedCrossRefGoogle Scholar
  3. 3.
    Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7:735.PubMedCrossRefGoogle Scholar
  4. 4.
    Thompson RH, Leibovich BC, Lohse CM, Zincke H, Blute ML. Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol. 2005;174:855.PubMedCrossRefGoogle Scholar
  5. 5.
    Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors: is there a difference in mortality and cardiovascular outcomes? J Urol. 2009;181:55–61 (discussion 61–52).PubMedCrossRefGoogle Scholar
  6. 6.
    Zini L, Perrotte P, Capitanio U, Jeldres C, Shariat SF, Antebi E, et al. Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer. 2009;115:1465–71.PubMedCrossRefGoogle Scholar
  7. 7.
    Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182:1271–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol. 2010;58:398–406.PubMedCrossRefGoogle Scholar
  9. 9.
    Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006;106:1276–85.PubMedCrossRefGoogle Scholar
  10. 10.
    Dash A, Vickers A, Schachter L, Bach AM, Snyder ME, Russo P. Comparison of outcomes in elective partial vs. radical nephrectomy for clear cell renal cell carcinoma of 4–7 cm. BJU Int. 2006;97:939–45.PubMedCrossRefGoogle Scholar
  11. 11.
    Patard JJ, Shvarts O, Lam JS, Pantuck AJ, Kim HL, Ficarra V, et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol. 2004;171:2181–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Go A, Chertow G, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305.PubMedCrossRefGoogle Scholar
  13. 13.
    Thompson RH, Kaag M, Vickers A, Kundu S, Bernstein M, Lowrance W, et al. Contemporary use of partial nephrectomy at a tertiary care center in the United States. J Urol. 2009;181:993–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Zini L, Patard JJ, Capitanio U, Crepel M, de La Taille A, Tostain J, et al. The use of partial nephrectomy in European tertiary care centers. Eur J Surg Oncol. 2009;35:636–42.PubMedCrossRefGoogle Scholar
  15. 15.
    Miller DC, Hollingsworth JM, Hafez KS, et al. Partial nephrectomy for small renal masses: an emerging quality of care concern? J Urol. 2006;175:853–7 (discussion 8).PubMedCrossRefGoogle Scholar
  16. 16.
    Dulabon LM, Lowrance WT, Russo P, Huang WC. Trends in renal tumor surgery delivery within the United States. Cancer. 2010;116:2316–21.PubMedGoogle Scholar
  17. 17.
    Sun M, Bianchi M, Trinh QD, Abdollah F, Schmitges J, Jeldres C, et al. Hospital volume is a determinant of postoperative complication, blood transfusion, length of stay after radical or partial nephrectomy. JURO. 2011;187(2):405–10.Google Scholar
  18. 18.
    Volpe A, Jewett MAS. The natural history of small renal masses. Nat Clin Pract Urol. 2005;2:384–90.PubMedCrossRefGoogle Scholar
  19. 19.
    Crispen PL, Viterbo R, Fox EB, Greenberg RE, Chen DY, Uzzo RG. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer. 2008;112:1051–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Abouassaly R, Lane BR, Novick AC. Active surveillance of renal masses in elderly patients. J Urol. 2008;180:505–8 (discussion 508–9).PubMedCrossRefGoogle Scholar
  21. 21.
    Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425–31.PubMedCrossRefGoogle Scholar
  22. 22.
    American Urological Association. Guidelines for management of the clinical stage I renal mass. In: Diagnosis and treatment recommendations. American Urological Association Education and Research Inc.; 2009.Google Scholar
  23. 23.
    Ljungberg B, Hanbury D, Kuczyk MA, et al. Guidelines on renal cell carcinoma. European Association of Urology; 2009:24–6.Google Scholar
  24. 24.
    Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007;178:41–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, et al. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2007;51:1606–15.PubMedCrossRefGoogle Scholar
  26. 26.
    Sun M, Thuret R, Abdollah F, Lughezzani G, Schmitges J, Tian Z, et al. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol. 2011;59(1):135–41.PubMedCrossRefGoogle Scholar
  27. 27.
    Chow WH, Devesa SS, Warren JL, Fraumeni JF. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628–31.PubMedCrossRefGoogle Scholar
  28. 28.
    Berndt SI, Carter HB, Schoenberg MP, Newschaffer CJ. Disparities in treatment and outcome for renal cell cancer among older black and white patients. J Clin Oncol. 2007;25:3589–95.PubMedCrossRefGoogle Scholar
  29. 29.
    Stephenson A, Hakimi A, Snyder M, Russo P. Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol. 2004;171:130–4.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2012

Authors and Affiliations

  • Maxine Sun
    • 1
  • Firas Abdollah
    • 1
    • 2
  • Marco Bianchi
    • 2
  • Quoc-Dien Trinh
    • 1
    • 3
  • Claudio Jeldres
    • 1
    • 4
  • Rodolphe Thuret
    • 5
  • Zhe Tian
    • 1
  • Shahrokh F. Shariat
    • 6
  • Francesco Montorsi
    • 2
  • Paul Perrotte
    • 4
  • Pierre I. Karakiewicz
    • 1
    • 4
  1. 1.Cancer Prognostics and Health Outcomes UnitUniversity of Montreal Health CentreMontrealCanada
  2. 2.Department of UrologyVita Salute San Raffaele UniversityMilanItaly
  3. 3.Vattikuti Urology InstituteHenry Ford Health SystemDetroitUSA
  4. 4.Department of UrologyUniversity of Montreal Health CentreMontrealCanada
  5. 5.Department of UrologyUniversity of Montpellier Health CenterMontpellierFrance
  6. 6.Department of UrologyWeill Medical College of Cornell UniversityNew YorkUSA

Personalised recommendations